Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Tempus AI Cl A (TEM)

Tempus AI Cl A (TEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine Business Wire - Thu Apr 23, 7:30AM CDT

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and the Keck School of Medicine of USC and Keck Medicine of USC, today announced a multi-faceted...

TEM : 52.12 (+1.32%)
Tempus to Report First Quarter 2026 Financial Results on May 5 Business Wire - Tue Apr 21, 7:30AM CDT

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it will report financial results for the first quarter ended March 31, 2026...

TEM : 52.12 (+1.32%)
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring Business Wire - Wed Apr 15, 7:30AM CDT

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Predicta Biosciences, a precision oncology company developing novel diagnostic solutions...

TEM : 52.12 (+1.32%)
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026 Business Wire - Tue Apr 14, 7:30AM CDT

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts—including one oral presentation—for the...

TEM : 52.12 (+1.32%)
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care Business Wire - Mon Apr 13, 7:30AM CDT

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of an automated clinical update service designed to support guideline-concordant...

TEM : 52.12 (+1.32%)
Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE Business Wire - Thu Apr 9, 7:30AM CDT

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced an expanded, multi-year collaboration with Gilead Sciences, Inc. (Nasdaq: GILD)...

GILD : 130.40 (-2.42%)
TEM : 52.12 (+1.32%)
Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference Business Wire - Wed Apr 8, 3:01PM CDT

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, will present at the 25th Annual Needham Virtual Healthcare Conference, taking place April 13-16....

TEM : 52.12 (+1.32%)
Image of Cathie Wood via Wikimedia Commons
3 ETFs to Buy Now If You Want to Invest Directly in OpenAI Barchart - Tue Apr 7, 1:04PM CDT

Cathie Wood’s ARK Invest is giving retail investors a rare shot at OpenAI, bringing pre-IPO AI exposure into ARKK, ARKW, and ARKF

ARKW : 139.77 (+2.23%)
$SPX : 7,165.08 (+0.80%)
CRCL : 99.66 (-0.35%)
COIN : 199.77 (+0.93%)
ARKK : 76.50 (unch)
SHOP : 125.83 (+1.29%)
ARKF : 42.85 (+1.64%)
TSLA : 376.30 (+0.69%)
CRSP : 48.78 (-11.59%)
AMD : 347.81 (+13.91%)
XYZ : 71.63 (+2.43%)
TEM : 52.12 (+1.32%)
Image of Cathie Wood via Wikimedia Commons
Bye Bye, AMD! Cathie Wood Ditches 57K Advanced Micro Shares Barchart - Wed Apr 1, 9:25AM CDT

Cathie Wood offloads AMD along with a bunch of other tech stocks as she moves away from semiconductor.

NVDA : 208.27 (+4.32%)
META : 675.03 (+2.41%)
ROKU : 115.22 (+0.23%)
CRCL : 99.66 (-0.35%)
AMD : 347.81 (+13.91%)
$IUXX : 27,303.67 (+1.95%)
TEM : 52.12 (+1.32%)
TSM : 402.46 (+5.17%)
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease Business Wire - Wed Apr 1, 7:30AM CDT

ALERT is the largest known multicenter, cluster-randomized trial to date evaluating an automated EHR-based notification system designed to address the undertreatment of significant valvular heart disease...

TEM : 52.12 (+1.32%)

Barchart Exclusives

3 Under-the-Radar Dividend Stocks Yielding Up to 13% That Wall Street Rates a Strong Buy Barchart - Fri Apr 24, 6:00PM CDT
Three under-the-radar dividend stocks offer yields up to 13%, bullish analyst ratings, and possible upside for income investors seeking overlooked names. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.